Fayez Sarofim & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $725M | Sell |
|
|||||
|
2025
Q1 | $779M | Sell |
|
|||||
|
2024
Q4 | $979M | Sell |
|
|||||
|
2024
Q3 | $1.45B | Sell |
|
|||||
|
2024
Q2 | $1.79B | Buy |
|
|||||
|
2024
Q1 | $1.52B | Buy |
|
|||||
|
2023
Q4 | $1.43B | Buy |
|
|||||
|
2023
Q3 | $1.06B | Buy |
|
|||||
|
2023
Q2 | $829M | Sell |
|
|||||
|
2023
Q1 | $840M | Buy |
|
|||||
|
2022
Q4 | $692M | Sell |
|
|||||
|
2022
Q3 | $520M | Buy |
|
|||||
|
2022
Q2 | $531M | Buy |
|
|||||
|
2022
Q1 | $529M | Sell |
|
|||||
|
2021
Q4 | $541M | Sell |
|
|||||
|
2021
Q3 | $473M | Sell |
|
|||||
|
2021
Q2 | $413M | Sell |
|
|||||
|
2021
Q1 | $335M | Sell |
|
|||||
|
2020
Q4 | $348M | Sell |
|
|||||
|
2020
Q3 | $347M | Sell |
|
|||||
|
2020
Q2 | $332M | Buy |
|
|||||
|
2020
Q1 | $254M | Sell |
|
|||||
|
2019
Q4 | $255M | Sell |
|
|||||
|
2019
Q3 | $234M | Buy |
|
|||||
|
2019
Q2 | $229M | Buy |
|
|||||
|
2019
Q1 | $234M | Buy |
|
|||||
|
2018
Q4 | $205M | Buy |
|
|||||
|
2018
Q3 | $210M | Sell |
|
|||||
|
2018
Q2 | $207M | Sell |
|
|||||
|
2018
Q1 | $229M | Sell |
|
|||||
|
2017
Q4 | $254M | Sell |
|
|||||
|
2017
Q3 | $242M | Sell |
|
|||||
|
2017
Q2 | $219M | Sell |
|
|||||
|
2017
Q1 | $181M | Sell |
|
|||||
|
2016
Q4 | $200M | Sell |
|
|||||
|
2016
Q3 | $244M | Sell |
|
|||||
|
2016
Q2 | $327M | Buy |
|
|||||
|
2016
Q1 | $322M | Sell |
|
|||||
|
2015
Q4 | $350M | Sell |
|
|||||
|
2015
Q3 | $341M | Sell |
|
|||||
|
2015
Q2 | $353M | Sell |
|
|||||
|
2015
Q1 | $359M | Buy |
|
|||||
|
2014
Q4 | $282M | Sell |
|
|||||
|
2014
Q3 | $322M | Sell |
|
|||||
|
2014
Q2 | $313M | Sell |
|
|||||
|
2014
Q1 | $320M | Sell |
|
|||||
|
2013
Q4 | $267M | Buy |
|
|||||
|
2013
Q2 | $232M | Buy |
|